Eurofins Viracor BioPharma Services Email Formats
Biotechnology Research • 
Lenexa, Kansas, United States • 51-100 Employees
Eurofins Viracor BioPharma Services Email Formats
Eurofins Viracor BioPharma Services uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@eurofins-viracor.com), used 50.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@eurofins-viracor.com | 50.8% |
{first initial}{last name} | jdoe@eurofins-viracor.com | 49.2% |
Key Contacts at Eurofins Viracor BioPharma Services
Karina Eterovic
Senior Director, Scientific Affairs
Mark Wissel
Director
James Furbee
Director Of Business Development
Danielle Medeiros
Director, Business Development At Eurofins Viracor And Eurofins Bioanalytical Services
Kirthi Kumar Kutumbaka
Associate Director
Doug Irving
Director Of Marketing, Biopharma Services
Company overview
| Headquarters | 18000 W 99th St, Lenexa, Kansas 66219, US |
| Phone number | +18003055198 |
| Website | |
| NAICS | 541714 |
| Keywords | Drug Development, Biomarkers, Clinical Trials, PCR, Immuno-Oncology, Immunotherapy, Cell Therapy, Gene Therapy, Allergy, Assay Development, Flow Cytometry, Cell-Based Assays, Vaccine Development, Oncology Research, Immunogenicity, Immunogenicity Testing, Cell Therapy Candidates, Gene Therapy Candidates, Genomic Profiling, Oncolytic Virus Candidates, Bioanalytical Testing, Pbmc Isolation |
| Founded | 1983 |
| Employees | 51-100 |
| Socials |
About Eurofins Viracor BioPharma Services
Eurofins Viracor BioPharma is a trusted provider of drug development solutions to pharmaceutical and contract research organizations. We offer complex/esoteric testing and assay development, to help advance your Phase 1-4 clinical trials through trusted partnership, scientific excellence, and exceptional service. For more than 40 years, Eurofins Viracor BioPharma has been dedicated to helping clients by providing high-quality, accurate results to evaluate the effects of drug candidates across all major therapeutic categories. We offer broad experience in molecular infectious disease testing, vaccine safety and efficacy assessment, immunogenicity, cell-based assays, allergy/hypersensitivity, and biomarker analysis. Our validated test list includes more than 3,000 assays, with new custom assays developed on a continual basis, in response to client needs. Expertise We’re driven to partner with you to solve difficult scientific problems, complementing your strategies with expertise in complex method development on multiple technology platforms, validation, and transfer. Our Research & Development team serves as an extension of your laboratory, with unique skills in technology platform selection and protocol design. Agility Eurofins Viracor BioPharma leverages over 40 different technology platforms and accepts a broad range of specimen types, widening our capabilities and enabling us to customize testing to your exact needs for your clinical trial combined with the scalability to manage trials of any size. We adhere to GCLP guidelines. Speed Our high-throughput laboratory can support your clinical trials with the capacity to process large sample volumes quickly, support studies with short set up timelines and provide rapid turnaround times. Our project managers and scientists act as part of your team – going above and beyond to get you the results you need when you need them. Accelerating your vaccine, compound, immune therapy or biological from bench to market.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Eurofins Viracor BioPharma Services has 29 employees across 6 departments.
Departments
Number of employees
Funding Data
Eurofins Viracor BioPharma Services has never raised funding before.
Australia
Spain
France
Kuwait
United KingdomFrequently asked questions
4.8
40,000 users
